Klassen Ann C, Lee Giyoung, Chiang Shawn, Murray Regan, Guan Mengfei, Lo Wen-Juo, Hill Larry, Leader Amy E, Manganello Jennifer, Massey Philip M
Drexel University Dornsife School of Public Health, Philadelphia, PA, United States.
Drexel University Dornsife School of Public Health, Philadelphia, PA, United States.
Vaccine. 2024 Mar 7;42(7):1704-1713. doi: 10.1016/j.vaccine.2024.01.105. Epub 2024 Feb 14.
In the U.S., uptake of the HPV vaccine remains below coverage goals. There is concern that negative reactions to emergency initiatives during the COVID-19 pandemic, including vaccination, may have increased some parents' hesitancy towards all vaccines, including HPV. Understanding how different parent populations view routine vaccination post-pandemic is key to strategic efforts to maintaining and increasing uptake of HPV vaccine.
In early 2022, we recruited an online panel of English-speaking U.S. parents and caregivers, who used the social media platform Twitter and had HPV vaccine-eligible but unvaccinated children age 9-14 years. Respondents completed a 20-minute survey measuring knowledge, attitudes and intentions regarding HPV vaccination for their child, as well as background socio-demographics and health information-seeking practices. Questions regarding experiences during the COVID-19 pandemic included changes in access to preventive care, and perceptions of whether pandemic experiences had positively or negatively affected their attitudes about routine vaccination, with open text capturing reasons for this change.
Among 557 respondents, 81 % were definitely or likely to vaccinate their child against HPV, with 12 % being uncertain, and 7 % unlikely to vaccinate. Regarding routine vaccination, most (70 %) felt their attitudes had not changed, while 26 % felt more positively, and only 4 % felt more negatively. Reasons for positive attitude change included increased appreciation for vaccines overall, and motivation to proactively seek preventive care for their child. Negative attitude changes stemmed from distrust of COVID-19 public health efforts including vaccine development, and disillusionment with vaccines' ability to prevent disease. In multivariable models, intention to vaccinate was greater among parents reporting greater education, Democratic affiliation, greater religiosity, and urban residence. Negative attitude change due to the pandemic independently predicted reduced HPV vaccination intention, while positive attitude change predicted positive intention.
Post-pandemic, most U.S. parents remain committed to vaccinating their children against HPV. However, addressing residual COVID-19 concerns could improve uptake among vaccine-hesitant parents.
在美国,人乳头瘤病毒(HPV)疫苗的接种率仍低于目标覆盖率。人们担心,在新冠疫情期间对包括疫苗接种在内的紧急举措的不良反应,可能增加了一些家长对所有疫苗(包括HPV疫苗)的犹豫态度。了解不同家长群体在疫情后对常规疫苗接种的看法,是维持和提高HPV疫苗接种率战略努力的关键。
2022年初,我们招募了一个说英语的美国父母和照顾者在线小组,他们使用社交媒体平台推特,且其9至14岁的孩子符合HPV疫苗接种条件但未接种。受访者完成了一项20分钟的调查,该调查测量了他们对孩子HPV疫苗接种的知识、态度和意图,以及背景社会人口统计学和健康信息寻求行为。关于新冠疫情期间经历的问题包括获得预防性护理的变化,以及对疫情经历是否对他们对常规疫苗接种的态度产生积极或消极影响的看法,并通过开放文本记录这种变化的原因。
在557名受访者中,81%肯定或可能为孩子接种HPV疫苗,12%不确定,7%不太可能接种。关于常规疫苗接种,大多数人(70%)觉得他们的态度没有改变,26%感觉更积极,只有4%感觉更消极。态度积极变化的原因包括对疫苗总体上的感激增加,以及主动为孩子寻求预防性护理的动力。态度消极变化源于对包括疫苗研发在内的新冠公共卫生努力的不信任,以及对疫苗预防疾病能力的幻灭感。在多变量模型中,报告受教育程度更高、属于民主党、宗教信仰更强和居住在城市的父母接种疫苗的意愿更高。疫情导致的消极态度变化独立预测了HPV疫苗接种意愿的降低,而积极态度变化则预测了积极意愿。
疫情后,大多数美国父母仍致力于为孩子接种HPV疫苗。然而,解决对新冠疫情残留的担忧可能会提高对疫苗犹豫的父母的接种率。